US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

KRRO

Korro Bio (KRRO)

Korro Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KRRO

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/13	06 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRRO	Korro Bio Inc
2024/06/13	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRRO	Korro Bio Inc
2024/06/13	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRRO	Korro Bio Inc
2024/06/05	08 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRRO	Korro Bio Inc
2024/05/31	05 : 01	GlobeNewswire Inc.	Korro to Participate in Upcoming June Investor and Scientific Conferences	NASDAQ:KRRO	Korro Bio Inc
2024/05/23	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:KRRO	Korro Bio Inc
2024/05/23	05 : 37	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KRRO	Korro Bio Inc
2024/05/21	03 : 30	GlobeNewswire Inc.	Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference	NASDAQ:KRRO	Korro Bio Inc
2024/05/15	09 : 22	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:KRRO	Korro Bio Inc
2024/05/15	05 : 34	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:KRRO	Korro Bio Inc
2024/05/15	05 : 20	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KRRO	Korro Bio Inc
2024/05/15	05 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRRO	Korro Bio Inc
2024/05/15	05 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KRRO	Korro Bio Inc
2024/05/15	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRRO	Korro Bio Inc
2024/05/15	05 : 01	GlobeNewswire Inc.	Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer	NASDAQ:KRRO	Korro Bio Inc
2024/04/18	21 : 30	GlobeNewswire Inc.	Korro Announces $70 Million Private Placement	NASDAQ:KRRO	Korro Bio Inc
2024/04/02	05 : 01	GlobeNewswire Inc.	Korro to Participate in Upcoming Investor Conferences	NASDAQ:KRRO	Korro Bio Inc
2024/03/27	05 : 01	GlobeNewswire Inc.	Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress	NASDAQ:KRRO	Korro Bio Inc
2024/02/27	22 : 00	GlobeNewswire Inc.	Korro to Present at the TD Cowen 44th Annual Health Care Conference	NASDAQ:KRRO	Korro Bio Inc
2024/01/18	22 : 00	GlobeNewswire Inc.	Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio	NASDAQ:KRRO	Korro Bio Inc
2024/01/09	23 : 02	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KRRO	Korro Bio Inc
2024/01/09	23 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRRO	Korro Bio Inc
2024/01/04	22 : 00	GlobeNewswire Inc.	Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:KRRO	Korro Bio Inc
2023/12/26	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:KRRO	Korro Bio Inc
2023/12/23	06 : 31	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KRRO	Korro Bio Inc
2023/12/21	06 : 44	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:KRRO	Korro Bio Inc
2023/12/07	22 : 00	GlobeNewswire Inc.	Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)	NASDAQ:KRRO	Korro Bio Inc
2023/12/02	06 : 07	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:KRRO	Korro Bio Inc
2023/11/30	06 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRRO	Korro Bio Inc
2023/11/30	06 : 53	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:KRRO	Korro Bio Inc

Showing the most relevant articles for your search:NASDAQ:KRRO

JP Morgan Chase

BNP Paribas (QX)

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

Financial Select Sector

American Express

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約